PATIENT INFORMATION LEAFLET

Similar documents
PATIENT INFORMATION LEAFLET. PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM RELESTAT, epinastine hydrochloride 0,5 mg/ml, eye drops

PATIENT INFORMATION LEAFLET. PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM LUMIGAN 0,01 %, bimatoprost 0,1 mg/ml eye drops

PATIENT INFORMATION LEAFLET

PATIENT INFORMATION LEAFLET

LUMIGAN EYE DROPS (bimatoprost 0.3 mg per ml)

Package leaflet: Information for the patient. Brimonidine Biogaran 2 mg/ml eye drops, solution. brimonidine tartrate

ALPHAGAN EYE DROPS BRIMONIDINE TARTRATE

This indication includes the temporary relief of burning, irritation, and/or discomfort due to dryness of the eye.

Package Leaflet: Information for the user. LUMIGAN 0.3 mg/ml, eye drops, solution, in single-dose container Bimatoprost

ZADITEN Eye Drops 1.0%

PATIENT INFORMATION LEAFLET: Lancap 15 mg and 30 mg. Please read this leaflet carefully before taking LANCAP capsules.

Dorzolamide 20 mg/ml Eye Drops, Solution

ACULAR EYE DROPS 5 mg/ml Eye Drops

Package leaflet: Information for the user Oftaquix 5 mg/ml eye drops, solution. Levofloxacin

Package leaflet: Information for the user. PRED MILD STERILE OPHTHALMIC SUSPENSION 0.12% w/v Eye Drops, Suspension Prednisolone Acetate

ENIDIN EYE DROPS [brimonidine tartrate]

INDICATIONS ACULAR 0,5 % is indicated for the relief of inflammation following ocular surgery.

APO-Latanoprost Contains the active ingredient latanoprost

PATIENT INFORMATION LEAFLET. PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM OZURDEX, dexamethasone 700 μg intravitreal implant

APO-Olopatadine Eye Drops Contains the active ingredient olopatadine (as olopatadine hydrochloride)

Read this entire leaflet carefully before you start taking DYNA BEZAFIBRATE. If you have further questions, please ask your doctor or your pharmacist.

PACKAGE LEAFLET: INFORMATION FOR THE USER ACULAR 0.5% w/v EYE DROPS, SOLUTION (Ketorolac trometamol)

Zovirax Ophthalmic (eye) Ointment Acyclovir

SCHEDULING STATUS Schedule 4 PROPRIETARY NAME AND DOSAGE FORM

INDICATIONS ACULAR 0,4% ophthalmic solution is indicated for the reduction of ocular pain and burning/stinging following corneal refractive surgery.

PRED FORTE 1% w/v Eye Drops, Suspension Prednisolone acetate

Pilocarpine 2% w/v Eye Drops, solution. Pilocarpine 4% w/v Eye Drops, solution. Pilocarpine Hydrochloride

BrinzoQuin Eye Drops 1.0%

PATIENT INFORMATION LEAFLET TEXAMER

It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist.

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. IOPIDINE 1% Apraclonidine Ophthalmic Solution, USP

Package leaflet: Information for the user. Relestat, 0.5 mg/ml, eye drops, solution Epinastine hydrochloride

PATIENT INFORMATION LEAFLET SIMVACOR RANGE

IOPIDINE 5mg/ml Eye Drops, solution contain apraclonidine (as hydrochloride) as the active substance.

Package Leaflet - Information for the User. TOBRADEX 3 mg/ml/1 mg/ml Eye Drops, Suspension Tobramycin and Dexamethasone

NEVANAC TM 0.1% Eye Drops

PATIENT INFORMATION LEAFLET FOR TEXA 10 mg TABLETS AND TEXA SYRUP PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM:

Package leaflet: Information for the user. NEVANAC 1 mg/ml eye drops, suspension Nepafenac

Package leaflet: Information for the user. <product name> 3 mg/ml eye drops, solution. Ofloxacin

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. XIIDRA TM* Lifitegrast Ophthalmic Solution 5%

MURINE HAYFEVER RELIEF 2% W/V EYE DROPS Sodium Cromoglicate

TENOPT timolol maleate

TRIPROLIDINE. Please read this leaflet and the packaging of the medicine you purchased, carefully before you start using triprolidine.

PATIENT INFORMATION LEAFLET BILOCOR RANGE

PATIENT INFORMATION LEAFLET ZYTOMIL RANGE

PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM: Read this entire leaflet carefully before you start taking DYNAFLOC.

Otodex Framycetin sulfate (fra-me-see-tin sul-fate), Gramicidin (grammy-sigh-din), Dexamethasone (dex-ar-meth-arsone)

PATIENT INFORMATION LEAFLET PEPLOC RANGE

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. T-LO Timolol Ophthalmic Solution (0.25%, 0.

NAPHCON-A Eye Drops naphazoline hydrochloride 0.025% and pheniramine maleate 0.3%.

PHENYLEPHRINE. Please read this leaflet and the label of the medicine you purchased, carefully before you start using Phenylephrine.

TIMALEN 0.5% eye drops

Consumer Medicine Information TOPICIL. Please read this leaflet carefully before you start using Topicil Capsules.

PATIENT INFORMATION LEAFLET

PHOLCODINE. Please follow the instructions on the packaging of the medicine you purchased and in this leaflet before you start using pholcodine.

Zatamil Mometasone furoate 0.1% w/w

PATIENT INFORMATION LEAFLET DYNAFIL RANGE

Package leaflet: Information for the user. Carmellose sodium

Package leaflet: Information for the user. GANFORT 0.3 mg/ml + 5 mg/ml eye drops, solution Bimatoprost/timolol

CIPROXIN HC Ear Drops

PATIENT INFORMATION LEAFLET SINTAIR RANGE

TOBREX TM EYE DROPS and EYE OINTMENT 0.3%

PATIENT INFORMATION LEAFLET FOR FEDALOC 30 mg / 60 mg SR TABLETS. Please read this leaflet carefully before you start taking FEDALOC tablets.

VOLTAREN OPHTHA Eye Drops 0.1%

Package leaflet: Information for the user. COMBIGAN 2 mg/ml + 5 mg/ml eye drops, solution Brimonidine tartrate and timolol

Instil one or two drops in the conjunctival sac(s) every three to four hours as needed.

PATIENT INFORMATION LEAFLET POLLENTYME S AND TABS

PACKAGE LEAFLET: INFORMATION FOR THE USER ToboDexin 3 mg/g+1 mg/g eye ointment Tobramycin + Dexamethasone

PATIENT INFORMATION LEAFLET EFFERFLU C IMMUNE BOOSTER. EFFERFLU C IMMUNE BOOSTER has not been evaluated by the Medicines Control

Patient Information COSOPT PF (CO-sopt PEA EHF) (dorzolamide hydrochloride-timolol maleate ophthalmic solution) 2%/0.5%

All medicines have risks and benefits. Your doctor has weighed the risks of you taking Triprim against the benefits he or she expects it will have.

Package Leaflet: Information for the user. NEVANAC 3 mg/ml eye drops, suspension nepafenac

Ceclor CD cefaclor monohydrate sustained release tablets

NOVASONE Mometasone furoate

Epilepsy is a condition where you have repeated seizures (fits). There are many different types of seizures, ranging from mild to severe.

POLLENTYME S and Tabs Pharma Dynamics (Pty) Ltd Version: July 2017 (G1639) Word copy of G1639 PATIENT INFORMATION LEAFLET FOR POLLENTYME S AND TABS

Package leaflet: Information for the user. GANFORT 0.3 mg/ml + 5 mg/ml eye drops, solution, in single-dose container Bimatoprost/timolol

MAXIDEX Eye Drops 0.1%

Colofac mebeverine hydrochloride

SANDOMIGRAN. 0.5mg tablet Pizotifen malate

MIDAZOLAM APOTEX Solution for Injection Contains the active ingredient midazolam

Apo-Ciclopirox ciclopirox USP 8% w/w Nail Lacquer (Topical Solution)

CONSUMER MEDICINE INFORMATION

ISOPTO CARPINE Eye Drops

DALACIN C PHOSPHATE Injection Clindamycin phosphate

Pemetrexed APOTEX Powder for Injection Contains the active ingredient pemetrexed (as disodium)

If you have any concerns about taking this medicine, ask your doctor or pharmacist.

CILOXAN TM Eye Drops 0.3%

PRESCRIBING INFORMATION

PRESCRIBING INFORMATION WITH CONSUMER INFORMATION MYDRIACYL. tropicamide ophthalmic solution, USP. 0.5% and 1% w/v.

DORZOLAMIDE/ TIMOLOL SANDOZ 20/5

Fluticasone propionate, 50 mcg per spray. Please read this leaflet carefully before you use FLIXONASE ALLERGY & HAYFEVER 24 HOUR.

COSDOR. What is in this leaflet. Before you use COSDOR. What COSDOR is used for. Dorzolamide hydrochloride/timolol maleate

Package leaflet: Information for the user. Cefixime ABR 100 mg/5 ml powder for oral suspension Cefixime

DUOTRAV Eye Drops travoprost 0.004% and timolol 0.5%

PATIENT INFORMATION LEAFLET ZOXADON TABLETS RANGE

Transcription:

Page 1 PATIENT INFORMATION LEAFLET Please read this leaflet carefully before using COMBIGAN. Keep this leaflet. You may need to read it again. If you have any further questions, please ask your doctor or your pharmacist. This medication is prescribed for the particular condition that you have. Never give this medication to others. It may harm them, even if their symptoms are the same as yours. Scheduling Status Schedule 3 Proprietary Name and Dosage Form COMBIGAN ophthalmic solution (each ml of sterile solution contains brimonidine tartrate 2,0 mg and timolol maleate equivalent to timolol 5,0 mg) WHAT COMBIGAN CONTAINS Active ingredients: The medicinal ingredients in COMBIGAN are brimonidine tartrate and timolol maleate. Preservative: Benzalkonium chloride 0,005 % Inactive ingredients: Monobasic sodium phosphate monohydrate; dibasic sodium phosphate heptahydrate; purified water. Hydrochloric acid and/or sodium hydroxide may be added to adjust ph. WHAT COMBIGAN IS USED FOR What kind of medication is COMBIGAN and how does it work Your eye contains a clear, watery liquid that feeds the inside of the eye. Liquid is constantly being drained out of the eye and new liquid is made to replace this. If the liquid cannot drain out quickly enough, the pressure inside the eye builds up. COMBIGAN is a preserved eye drop solution that reduces the amount of fluid flowing into the eye and increasing the amount of fluid flowing out of the eye. What is COMBIGAN for COMBIGAN eye drops are used to reduce high pressure in the eye (intraocular pressure). This high pressure can lead to a disease called glaucoma. If the high pressure is not reduced, it could eventually damage your sight.

Page 2 BEFORE YOU USE COMBIGAN Before using COMBIGAN you should tell your doctor if You have any medical problems now or have had any in the past, especially asthma or other lung problems or heart problems. You have allergies to any medications. You wear contact lenses. The preservative in COMBIGAN, benzalkonium chloride, may be absorbed by soft (hydrophilic) contact lenses. Lenses should be removed prior to application of COMBIGAN and not re-inserted earlier than 15 minutes after use. You are pregnant or intend to become pregnant. You are breast-feeding or intend to breast-feed. You have or have had kidney or liver problems in the past. Do not use COMBIGAN if you Are allergic to any of its components. Have asthma or have ever had asthma. Have chronic obstructive lung disease. Have certain heart disease or conditions. Have diabetes or are subject to low blood sugar levels without apparent cause. Are receiving monoamine oxidase (MAO) inhibitor therapy. Are breast feeding or pregnant. Pregnancy and breast-feeding Do not use COMBIGAN if you are pregnant or breast-feeding your baby. Tell your doctor if you have the intention of becoming pregnant or if you are planning to start breast-feeding. Driving and using machinery COMBIGAN may cause drowsiness and fatigue in some patients. Caution should be exercised when engaged in activities where mental alertness is required. Using other medicines with COMBIGAN If you are taking other medicines on a regular basis, including complementary or traditional medicines, the use of COMBIGAN with these medicines may cause undesirable interactions. Tell your doctor or pharmacist if you are taking any other medicines, including any you have bought at your pharmacy, supermarket or health food shop. This is particularly important if you are taking medicine to lower blood pressure or to treat heart disease. INSTRUCTIONS ON HOW TO TAKE THIS MEDICINE How to use COMBIGAN COMBIGAN was prescribed by your doctor to treat your specific medical problem and is for your use only. Do not share with others. The usual dose is one drop in the affected eye(s) in the morning and in the evening.

Page 3 If you are using COMBIGAN with another eye drop, the drops should be instilled at least 10 minutes apart. Your doctor may have told you to use COMBIGAN in a different way to that recommended in this leaflet. If so, follow your doctor s instructions about when and how to use the eye drops. Read the directions on your prescription label carefully. Ask your doctor or pharmacist to explain anything that you do not understand. Do not change the dosage of the drug without consulting your physician. If you must stop treatment contact your physician immediately. Do not start taking any other medicines unless you have discussed the matter with your physician. If you develop any eye irritation or any new eye problems such as redness of the eye or swelling of the eyelid, contact your physician immediately. If you suspect that COMBIGAN is causing an allergic reaction, stop its use and contact your physician as soon as possible. Avoid allowing the tip of the dispensing container to contact the eye or surrounding structures. Ocular solutions, if handled improperly or if the tip of the dispensing container contacts the eye or surrounding structures, can be contaminated by common bacteria known to cause ocular infections. Serious damage to the eye and subsequent loss of vision may result from using contaminated solutions. If you have ocular surgery or develop any other ocular condition (e.g. trauma or infection), you should immediately seek your physician s advice concerning the continued use of COMBIGAN. Use in children COMBIGAN is not recommended for children. If you use more COMBIGAN than you should In the event of overdosage, consult your doctor or pharmacist. If neither is available, seek help at the nearest hospital or poison control centre. If you forget to use COMBIGAN If you forget to apply your eye drops at your normal time, simply apply them as soon as your remember. Then go back to the original schedule as directed by your doctor. Don t try to catch up on missed drops by applying more than one dose at a time. SIDE EFFECTS COMBIGAN can have side effects. Not all side effects reported for this medicine are included in this leaflet. Should your general health worsen while taking this medicine, please consult your doctor, pharmacist or other health care professional for advice.

Page 4 Some common side-effects which may occur include: redness of eyes or inside of eyelids; irritation, itching or inflammation of eyes or eyelids; swelling of eye or eyelid; eye discharge; dry mouth; burning/stinging eye(s); blurred vision; feeling of something in the eye; headache; tiredness/drowsiness. If these persist or cause you concern, consult your doctor. Be sure to tell your doctor (or pharmacist) promptly about any side effects or any unusual symptom. STORAGE AND DISPOSAL INFORMATION Store below 25 C and protect from light. Do not refrigerate. Keep all medicines out of reach and sight of children. The EXPIRY date is marked on the bottle. Do not use the ophthalmic solution past the expiry date. Do not use the solution for longer than 30 days after opening the bottle. Keep the dispensing container tightly closed when not in use. If COMBIGAN is swallowed, contact your doctor or poison control centre. Return all unused medicines to your pharmacist. Do not dispose of unused medicines in drains or sewerage systems (e.g. toilets). PRESENTATION COMBIGAN ophthalmic solution is supplied in white, opaque plastic dropper bottles with a cap containing 5 ml. IDENTIFICATION COMBIGAN ophthalmic solution is a clear, greenish-yellow to light greenish-yellow solution, essentially free from particulate matter. REGISTRATION NUMBER A39/15.4/0464

Page 5 NAME, BUSINESS ADDRESS AND TELEPHONE NUMBER OF THE HOLDER OF THE CERTIFICATE OF REGISTRATION Allergan Pharmaceuticals (Pty) Ltd 30 New Road (entrance off Bavaria Road) Randjespark Ext 11, Midrand, 1682 Johannesburg, Gauteng SOUTH AFRICA Telephone number: 011 545 6600 DATE OF PUBLICATION OF THE PATIENT INFORMATION LEAFLET 20 October 2006